Financials

  • Market Capitalization 42.41 M
  • Employee 228
  • Founded 2008
  • CEO N/A
  • Website www.karyopharm.com
  • Headquarter Delaware, United States
  • FIGI BBG001J272L7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.68
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4306
EDSA
Edesa Biotech, Inc. - Common Shares
4.62 USD+0.43%+3.82%-12.67%+92.50%44.54 M USD
4320
ALGS
Aligos Therapeutics, Inc. - Common stock
6.91 USD-2.26%+7.63%+54.93%-29.42%43.10 M USD
4345
MREO
Mereo BioPharma Group plc - American Depositary Shares
0.25 USD-7.41%-13.79%-16.67%-85.63%39.92 M USD
4346
ACTU
Actuate Therapeutics, Inc. - Common stock
1.66 USD-1.78%+29.69%+38.33%-59.31%39.86 M USD

Notizie